BONVIVA IV drug use results surveillance
Phase of Trial: Phase IV
Latest Information Update: 20 Sep 2019
Price : $35 *
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Osteoporosis
- Focus Adverse reactions
- Sponsors Chugai Pharmaceutical
- 19 Sep 2019 Status changed from active, no longer recruiting to completed.
- 01 Jul 2015 Status changed from recruiting to active, no longer recruiting as per University Hospital Medical Information Network - Japan.
- 18 Mar 2014 New trial record